CHWY
Chewy, Inc.
CHWY has the edge over NKE overall, supported by stronger modeled upside and stronger fundamentals.
NKE
NIKE, Inc.
NKE has slightly lower modeled downside risk, despite its lower overall score.
CHWY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
CHWY's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
CHWY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 22x | $22.60 | — |
| Current | 34x | $22.60 | — |
| Cheap | 37x | $24.73 | +9.4% |
| Fair | 94x | $62.06 | +175% |
| Expensive | 623x | $411 | +1720% |
Historical ranges are pointers, not guarantees.
CHWY's PE is in its cheap range at 34x. If earnings grow as analysts expect, today's price would be 22x next year's earnings.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over CHWY in the historical PE scenario, which offers more potential upside but is not a forecast.
CHWY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
CHWY has the edge over NKE on the outlook, with more favorable valuation and earnings expectations.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
CHWY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.02 | +54% |
| Q3 2026 | $0.66 | +78% |
| Q2 2026 | $0.60 | -34% |
| Q1 2026 | $0.52 | -43% |
| Q4 2025 | $0.50 | -46% |
| Q3 2025 | $0.37 | -55% |
| Q2 2025 | $0.91 | +379% |
| Q1 2025 | $0.91 | +911% |
| Q4 2024 | $0.92 | +2967% |
CHWY has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
CHWY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.3B | +7.3% |
| Q2 2026 | $3.4B | +7.7% |
| Q1 2026 | $3.3B | +0.5% |
| Q4 2025 | $3.1B | +8.3% |
| Q3 2025 | $3.1B | +8.6% |
| Q2 2025 | $3.1B | +8.3% |
| Q1 2025 | $3.2B | +14% |
| Q4 2024 | $2.9B | +5.1% |
CHWY has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.8% | +0.5 points |
| Q2 2026 | 3.8% | +1.4 points |
| Q1 2026 | 1.3% | +1.6 points |
| Q4 2025 | 2.1% | +1.2 points |
| Q3 2025 | 2.3% | +1.1 points |
| Q2 2025 | 2.5% | +0.2 points |
| Q1 2025 | -0.3% | +0.4 points |
| Q4 2024 | 0.9% | +1.3 points |
CHWY's operating margin was 2.8% last quarter, up 0.5 points from the same quarter a year ago, near the top of its range since 2019.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over CHWY on profitability, with a higher operating margin.
CHWY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $89.5M | -15% |
| Q2 2026 | $70.8M | +45% |
| Q1 2026 | $232M | +48% |
| Q4 2025 | $175.8M | +16% |
| Q3 2025 | $105.9M | +16% |
| Q2 2025 | $48.7M | -7.5% |
| Q1 2025 | $156.6M | +136% |
| Q4 2024 | $151.8M | +213% |
CHWY has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
CHWY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.1% | -9M shares |
| 1 year | -4.3% | -18.3M shares |
| 3 years | -5% | -21.5M shares |
| 5 years | -1.6% | -6.6M shares |
| Available history | +2.2% | +8.8M shares |
CHWY has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $200M |
| Q2 2026 | $200M |
| Q1 2026 | $55M |
| Q4 2025 | $54.9M |
| Q3 2025 | $129.5M |
| Q2 2025 | $23.1M |
| Q1 2025 | $67.7M |
| Q4 2024 | $343.2M |
CHWY spent $510M buying back its own shares over the past year, down 9.5% from the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
CHWY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -2.1x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | -2.6x | Net Cash |
| Q1 2025 | -2.6x | Net Cash |
| Q4 2024 | -2.4x | Net Cash |
CHWY has the edge over NKE on leverage, with a lower net debt burden relative to earnings.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
CHWY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.2 | Neutral |
| Stochastic | 58.6 | Neutral |
CHWY's weekly RSI is 51 (neutral) and its Stochastic is 59 (neutral).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
CHWY PE vs Consumer Cyclical Sector
| Metric | CHWY | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 18x | 90% above |
| PE % | 7 | 47 | 40 pts below |
CHWY is trading at 34x earnings, a 90% premium to the Consumer Cyclical sector's median of 18x.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE has the edge over CHWY on valuation relative to its sector.
CHWY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.6 | 9.8% above |
| 20 week MA | $21.4 | 5.4% above |
| 50 week MA | $24.4 | 7.5% below |
| 100 week MA | $31.0 | 27% below |
| 200 week MA | $29.0 | 22% below |
CHWY has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
CHWY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.6 | $104.0 | +263% |
| 2021 | $104.0 | $59.3 | -43% |
| 2022 | $59.3 | $39.3 | -34% |
| 2023 | $39.3 | $23.6 | -40% |
| 2024 | $23.6 | $34.1 | +44% |
| 2025 | $34.1 | $32.5 | -4.6% |
| 2026 YTD | $32.5 | $22.6 | -30% |
CHWY has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.